Inotropy | Esmolol | Baseline | DBT | RMANOVA | |
F value | p Value | ||||
SRmax (s−1) | 0.65 (0.13)* | 1.05 (0.16) | 1.88 (0.17)*† | 63.755 | <0.001 |
Mw (mW.s/ml) | 1.36 (0.25)* | 2.03 (0.10) | 3.15 (0.36)*† | 91.481 | <0.001 |
ISAmax (s−2) | 39 (8)* | 90 (29) | 224 (48)*† | 53.799 | <0.001 |
Pacing | HR 100 | HR 120 | HR 140 | RMANOVA | |
F value | p Value | ||||
SRmax (s−1) | 1.15 (0.27) | 1.24 (0.30) | 1.29 (0.30) | 1.955 | 0.192 |
Mw (mW.s/ml) | 2.78 (0.52) | 2.42 (0.27) | 2.60 (0.55) | 0.960 | 0.416 |
ISAmax (s−2) | 54 (20) | 70 (30) | 88 (40)* | 11.104 | 0.003 |
Loading | Baseline | Low preload | Baseline | High afterload |
SRmax (s−1) | 1.19 (0.16) | 1.14 (0.44) | 1.05 (0.41) | 0.73 (0.25)* |
Mw (mW.s/ml) | 2.17 (0.54) | 2.08 (0.58) | 2.19 (0.63) | 2.47 (1.21) |
ISAmax (s−2) | 67 (28) | 84 (21) | 56 (22) | 64 (45) |
Values are means (SD).
DBT, dobutamine infusion at 3 μg/kg/min; HR, heart rate during atrial pacing in beats per minute; ISAmax, maximal isovolumic strain acceleration; Mw, slope of the preload recruitable stroke work relationship; RMANOVA, repeated measurements analysis of variance; SRmax, maximal strain rate.
*p<0.05 in comparison with baseline or HR 100.
†p<0.05 DBT in comparison with esmolol.